Glypican-3 antibody [1G12]
GTX01702
ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetGPC3
Overview
- SupplierGeneTex
- Product NameGlypican-3 antibody [1G12]
- Delivery Days Customer9
- Application Supplier NoteIHC-P: 1:100-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1G12
- ConjugateUnconjugated
- Gene ID2719
- Target nameGPC3
- Target descriptionglypican 3
- Target synonymsDGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1, glypican-3, glypican proteoglycan 3, heparan sulphate proteoglycan, intestinal protein OCI-5, secreted glypican-3
- HostMouse
- IsotypeIgG1
- Protein IDP51654
- Protein NameGlypican-3
- Scientific DescriptionCell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Murakami T, Yao T, Yatagai N, et al. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases. Histopathology. 2020,76(2):325-332. doi: 10.1111/his.13973Read this paper
- Cabibi D, Bisanti A, Lanza D, et al. Glypican-3 and Hep Par-1 are Useful Biomarkers in the Cytologic Assessment of Ascites. Appl Immunohistochem Mol Morphol. 2019,27(1):65-69. doi: 10.1097/PAI.0000000000000548Read this paper
- Park H, Kim M, Kim HJ, et al. Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) function as endocytic receptors for an internalizing anti-nucleic acid antibody. Sci Rep. 2017,7(1):14373. doi: 10.1038/s41598-017-14793-zRead this paper
- Li B, Liu H, Shang HW, et al. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients. Afr Health Sci. 2013,13(3):703-9. doi: 10.4314/ahs.v13i3.26Read this paper
- Feng M, Gao W, Wang R, et al. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2013,110(12):E1083-91. doi: 10.1073/pnas.1217868110Read this paper


